PL4396183T3 - Podstawione pochodne s-alaninianu - Google Patents

Podstawione pochodne s-alaninianu

Info

Publication number
PL4396183T3
PL4396183T3 PL22769666.3T PL22769666T PL4396183T3 PL 4396183 T3 PL4396183 T3 PL 4396183T3 PL 22769666 T PL22769666 T PL 22769666T PL 4396183 T3 PL4396183 T3 PL 4396183T3
Authority
PL
Poland
Prior art keywords
alaninate
derivatives
substituted
alaninate derivatives
Prior art date
Application number
PL22769666.3T
Other languages
English (en)
Inventor
Hartmut Beck
Stefanie MESCH
Alexandros Vakalopoulos
Nils PFAFF
Stefanie Zimmermann
Markus Follmann
Elisabeth KERSTEN
Guillaume Levilain
Katrin PARTIKEL
Andreas Peter BROEHL
Stefan Heitmeier
Julia DIETZE-TORRES
Lutz Lehmann
Kersten Matthias Gericke
Frank SÜSSMEIER
Lars BÄRFACKER
Alexander Hillisch
Adrian Tersteegen
Anja BUCHMÜLLER
Christoph Gerdes
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of PL4396183T3 publication Critical patent/PL4396183T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL22769666.3T 2021-09-03 2022-08-29 Podstawione pochodne s-alaninianu PL4396183T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21194781 2021-09-03
PCT/EP2022/073889 WO2023031083A1 (en) 2021-09-03 2022-08-29 Substituted s-alaninate derivatives

Publications (1)

Publication Number Publication Date
PL4396183T3 true PL4396183T3 (pl) 2026-02-09

Family

ID=77640441

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22769666.3T PL4396183T3 (pl) 2021-09-03 2022-08-29 Podstawione pochodne s-alaninianu

Country Status (30)

Country Link
US (2) US20250002483A1 (pl)
EP (1) EP4396183B1 (pl)
JP (1) JP7546172B2 (pl)
KR (1) KR20240055043A (pl)
CN (1) CN117916236A (pl)
AR (1) AR126980A1 (pl)
AU (1) AU2022338082A1 (pl)
CA (1) CA3230721A1 (pl)
CL (1) CL2024000638A1 (pl)
CO (1) CO2024002668A2 (pl)
CR (1) CR20240114A (pl)
DK (1) DK4396183T3 (pl)
DO (1) DOP2024000024A (pl)
EC (1) ECSP24024658A (pl)
ES (1) ES3055022T3 (pl)
FI (1) FI4396183T3 (pl)
GE (2) GEAP202416491A (pl)
HR (1) HRP20251414T1 (pl)
IL (1) IL310777A (pl)
LT (1) LT4396183T (pl)
MA (1) MA66371B1 (pl)
MX (1) MX2024002750A (pl)
PE (1) PE20240798A1 (pl)
PL (1) PL4396183T3 (pl)
PT (1) PT4396183T (pl)
RS (1) RS67431B1 (pl)
SI (1) SI4396183T1 (pl)
TW (1) TW202320754A (pl)
WO (1) WO2023031083A1 (pl)
ZA (1) ZA202402553B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4669644A1 (en) * 2023-02-21 2025-12-31 Bayer Aktiengesellschaft SUBSTITUTED S-ALANINATE DERIVATIVES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0042675A1 (en) 1980-06-20 1981-12-30 Norton Company Method of mounting a grinding wheel on a spindle
EP2254881B1 (en) 2008-02-21 2012-09-12 Sanofi Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin
SI2989095T1 (sl) 2013-04-26 2019-03-29 Sanofi Tartratna sol 5-kloro-tiopen-2-karboksilne kisline((s)-2-(metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino)-3- (4-metil piperazin-1 il)-3-okso-propril)amida

Also Published As

Publication number Publication date
EP4396183B1 (en) 2025-09-03
PE20240798A1 (es) 2024-04-18
FI4396183T3 (fi) 2025-12-04
CO2024002668A2 (es) 2024-03-07
JP7546172B2 (ja) 2024-09-05
ZA202402553B (en) 2025-09-25
JP2024509511A (ja) 2024-03-04
KR20240055043A (ko) 2024-04-26
LT4396183T (lt) 2025-11-25
RS67431B1 (sr) 2025-12-31
EP4396183A1 (en) 2024-07-10
CN117916236A (zh) 2024-04-19
AR126980A1 (es) 2023-12-06
DK4396183T3 (da) 2025-11-17
GEP20257776B (en) 2025-06-25
CL2024000638A1 (es) 2024-07-05
MX2024002750A (es) 2024-03-27
HRP20251414T1 (hr) 2026-01-02
ES3055022T3 (en) 2026-02-09
SI4396183T1 (sl) 2026-01-30
GEAP202416491A (en) 2024-05-10
TW202320754A (zh) 2023-06-01
CR20240114A (es) 2024-05-22
IL310777A (en) 2024-04-01
US20230391761A1 (en) 2023-12-07
ECSP24024658A (es) 2024-04-30
DOP2024000024A (es) 2024-03-28
AU2022338082A1 (en) 2024-02-15
PT4396183T (pt) 2025-11-25
MA66371B1 (fr) 2025-12-31
US20250002483A1 (en) 2025-01-02
CA3230721A1 (en) 2023-03-09
US11912692B2 (en) 2024-02-27
WO2023031083A1 (en) 2023-03-09

Similar Documents

Publication Publication Date Title
IL298264B1 (en) Microbiocidal derivatives
ZA202204675B (en) New methylquinazolinone derivatives
SG11202110922QA (en) Camptothecin derivatives
IL289197B2 (en) History of 2–hydroxycycloalkane–1–carbamoyl
IL293968B2 (en) History of furoindazole
IL290815A (en) History of alpha-d-galactopyranoside
IL283990A (en) Modified oxopyridine derivatives
ZA202106024B (en) Heterocyclic derivatives
IL290964A (en) A 2-aminoquinazolinone derivative
SG11202012594RA (en) Spirochromane derivatives
IL288950A (en) History of pyridine-3-yl
SI3796975T1 (sl) Derivati sulfonilaminobenzamida
PL3770162T3 (pl) Pochodne dihydrochromenu
ES3055022T3 (en) Substituted s-alaninate derivatives
IL304189A (en) Pyrazolamide derivatives
GB201919213D0 (en) Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds
IL319945A (en) New Modified Pyrazine-Carboxamide History
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
GB201906270D0 (en) Microbiocidal derivatives
GB201906269D0 (en) Microbiocidal derivatives
GB201906272D0 (en) Microbiocidal derivatives
GB201906274D0 (en) Microbiocidal derivatives
HK40058409A (en) Imidozopyrimidine derivatives
GB201806948D0 (en) Derivatives